Almirall, S.A. (ALMRY)

Verve Therapeutics Revenue

Almirall had revenue of 277.27M EUR in the quarter ending June 30, 2025, with 10.35% growth. This brings the company's revenue in the last twelve months to 1.05B, up 13.13% year-over-year. In the year 2024, Almirall had annual revenue of 990.63M with 10.22% growth.

• Revenue (ttm): 1.05B EUR
• Revenue Growth: +13.13%
• P/S Ratio: 2.05
• Revenue / Employee: 520.20K EUR
• Employees: 2,026
• Market Cap: 2.54B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	990.63M	91.84M	10.22%
Dec 31, 2023	898.79M	20.28M	2.31%
Dec 31, 2022	878.51M	42.01M	5.02%
Dec 31, 2021	836.50M	22.01M	2.70%
Dec 31, 2020	814.49M	-96.17M	-10.56%